Osteoporosis

Edit Answers
1234567891011121314151617181920212223242526272829303132333435
Across
  1. 6. Risk factor for osteoporosis
  2. 9. 50% of women with_____ fractures are unable to walk independently after their fracture heals.
  3. 11. subcutaneous injection daily for osteoporosis
  4. 12. Alendronate, Risedronate, ibandroante
  5. 13. Related to the GI tract
  6. 15. Medication risk factor
  7. 18. Deficiency associated with hypophosphatemia and hypocalcemia
  8. 19. a measurement for bone density compared to people of the same age
  9. 23. Sensitive screening test for above
  10. 24. The lifetime risk of a hip fracture in a woman with T-score of 0
  11. 25. Best locations for measuring bone density
  12. 26. Chronic daily use above 7.5mg prednisone or equivalent associated with bone loss
  13. 30. ________ less than 127lbs (risk factor)
  14. 32. A monoclonal antibody against _____, denosumab (Prolia)
  15. 33. Severe side effect of medications above, higher in patients with cancer receiving IV version
  16. 34. Disease associated with chronic malabsorption occurring in ~1% Caucasian women
  17. 35. ___________ history of a hip fracture (risk factor)
Down
  1. 1. disordered mineralization of newly formed bone protein matrix, associated with low serum phosphate and elevated serum alkaline phosphatase
  2. 2. Repeat measures of bone density every 1-2 years after starting _______.
  3. 3. Women older than ________ should have a bone mineral density test.
  4. 4. Activity resulting in a 5-10% reduction in bone density
  5. 5. 200 IU daily nasal spray for treatment of osteoporosis
  6. 7. lab evaluation for secondary osteoporosis (calcium, phosphorus, albumin, alkaline phosphatase
  7. 8. 800 _______ of vitamin D daily
  8. 9. thyroid risk factor
  9. 10. Daily requirement of 1,000 – 1,500 mg in divided doses with meals
  10. 14. SERM FDA approved for prevention and treatment of osteoporosis
  11. 16. Lab measurement for secondary causes of osteoporosis (parathyroid hormone, TSH, 25-hydroxyvitamin D
  12. 17. offered to women without preexisting fractures and T-score <-2.0, women with T-score -1.5 and another clinical risk factor, and women with prior osteoporotic fractures
  13. 20. 50% of _______ older than 50 years will experience an osteoporotic fracture
  14. 21. IV medication given yearly
  15. 22. Exercise important for increasing bone mineral density
  16. 23. duel-energy x-ray ________
  17. 27. A disease of the bone characterized by a predisposition to low-trauma fracture caused by low bone mass and disordered microarchitecture.
  18. 28. a standard measurement for measuring bone density
  19. 29. T scores between -1.0 and -2.5
  20. 31. Prolonged premenopausal ______ (risk factor)